Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates the continued relevance of COVID-19 convalescent plasma (CCP) therapies. Lessons learnt from previous usage of CCP suggests focusing...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, David J., Franchini, Massimo, Joyner, Michael J., Casadevall, Arturo, Focosi, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617541/
https://www.ncbi.nlm.nih.gov/pubmed/36309490
http://dx.doi.org/10.1038/s41467-022-33864-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617541/
https://www.ncbi.nlm.nih.gov/pubmed/36309490
http://dx.doi.org/10.1038/s41467-022-33864-y

Ejemplares similares